HC Wainwright restated their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a report published on Monday,Benzinga reports. The brokerage currently has a $240.00 price target on the stock. Other equities analysts have also recently issued research reports about the company. Citigroup reaffirmed a “neutral” rating and issued a $166.00 price […]

HC Wainwright reiterated their buy rating on shares of Vir Biotechnology (NASDAQ:VIR – Free Report) in a research note published on Monday,Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. A number of other equities analysts also recently commented on VIR. Raymond James Financial assumed coverage on Vir Biotechnology in a […]

HC Wainwright restated their buy rating on shares of Bright Minds Biosciences (NASDAQ:DRUG – Free Report) in a report published on Monday,Benzinga reports. They currently have a $85.00 target price on the stock. Several other equities research analysts also recently weighed in on DRUG. BTIG Research started coverage on shares of Bright Minds Biosciences in […]